Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Burdick

Showing results (231-240 of 261) with videos related to

Pageof 27
Sort By:
Glycobiology|July 11, 2001
In vivo glycosylation of mucin tandem repeatsH S Silverman, S Parry, M Sutton-Smith, et al.
The Journal of Clinical Investigation|August 24, 2001
Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndromeJ A Belperio, M P Keane, M D Burdick, et al.
Cancer Research|December 17, 2005
Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesotheliomaArminder S Jassar, Eiji Suzuki, Veena Kapoor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritisM M Halloran, J M Woods, R M Strieter, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 1995
Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis. A compartmental analysisD R Smith, S L Kunkel, T J Standiford, et al.
The Journal of Experimental Medicine|September 1, 1996
Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastasesD A Arenberg, S L Kunkel, P J Polverini, et al.
Toxicology and Applied Pharmacology|January 14, 2025
In vitro NIH3T3 mouse embryonic fibroblast cell model does not predict AAV2 or AAVdj-mediated cell transformationLuping Qiu, Steven W Kumpf, Elias M Oziolor, et al.
Plos One|July 7, 2011
Plasma chemokine levels are associated with the presence and extent of angiographic coronary collaterals in chronic ischemic heart diseaseEllen C Keeley, J Randall Moorman, Ling Liu, et al.
The American Journal of Pathology|September 1, 1993
The production of interleukin-1 receptor antagonist by human bronchogenic carcinomaD R Smith, S L Kunkel, T J Standiford, et al.
Regulatory Toxicology and Pharmacology : RTP|February 27, 2025
Nonclinical teratogenicity safety assessment of CRBN-engaging targeted protein degraders: Points to considerLise I Loberg, William R Proctor, Andrew D Burdick, et al.
Pageof 27

Showing results (231-240 of 261) with videos related to

Sort By:
Pageof 27
Glycobiology|July 11, 2001
In vivo glycosylation of mucin tandem repeatsH S Silverman, S Parry, M Sutton-Smith, et al.
The Journal of Clinical Investigation|August 24, 2001
Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndromeJ A Belperio, M P Keane, M D Burdick, et al.
Cancer Research|December 17, 2005
Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesotheliomaArminder S Jassar, Eiji Suzuki, Veena Kapoor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritisM M Halloran, J M Woods, R M Strieter, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 1995
Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis. A compartmental analysisD R Smith, S L Kunkel, T J Standiford, et al.
The Journal of Experimental Medicine|September 1, 1996
Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastasesD A Arenberg, S L Kunkel, P J Polverini, et al.
Toxicology and Applied Pharmacology|January 14, 2025
In vitro NIH3T3 mouse embryonic fibroblast cell model does not predict AAV2 or AAVdj-mediated cell transformationLuping Qiu, Steven W Kumpf, Elias M Oziolor, et al.
Plos One|July 7, 2011
Plasma chemokine levels are associated with the presence and extent of angiographic coronary collaterals in chronic ischemic heart diseaseEllen C Keeley, J Randall Moorman, Ling Liu, et al.
The American Journal of Pathology|September 1, 1993
The production of interleukin-1 receptor antagonist by human bronchogenic carcinomaD R Smith, S L Kunkel, T J Standiford, et al.
Regulatory Toxicology and Pharmacology : RTP|February 27, 2025
Nonclinical teratogenicity safety assessment of CRBN-engaging targeted protein degraders: Points to considerLise I Loberg, William R Proctor, Andrew D Burdick, et al.
Pageof 27